Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

Jun Li(Nanjing University of Chinese Medicine), Ting Yang(Nanjing University of Chinese Medicine)

Research Square

March 14, 2024

10.21203/rs.3.rs-4055631/v1

Cited by 0

Related Papers

Vascular Normalization: A New Window Opened for Cancer Therapies

|Frontiers in Oncology|2021|112

Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

|Molecular Medicine|2024|16